Creating Drugs at the Speed of AI | Absci
3,382,560 views 2 years ago
Let’s work together to create better biologics for patients, faster. Unlocking de novo design of therapeutic antibodies in silico could potentially reduce the time it takes to get new drug candidates into the clinic by more than half — while also increasing their probability of success in the clinic. We are the first to design and validate new therapeutic antibodies with zero-shot generative AI. Here’s our vision to deliver breakthrough therapeutics at the click of a button, for everyone. ---- There are thousands of life-saving therapies waiting to be discovered. But finding each one is like looking for a needle in a haystack. Meanwhile patients and loved ones wait, hoping for a miracle before it’s too late. What if we stopped looking for needles and started making them? Creating medicines we could never find because the antibodies don’t yet exist. We need high-quality data. Lots of it. And Artificial Intelligence built specifically to design these new antibodies. And a team of brilliant scientists to validate the designs in a state-of-the-art wet lab. We’d create new medicines in months instead of years. And could eventually design medicines for patients with the click of a button. This isn’t science fiction. We are the company unlocking the design of new antibodies on a computer… from scratch. And we’re just getting started With generative AI, we’re going to design more effective therapies that reach our loved ones faster. Driving the future of drug creation, because those who need life-saving therapies don’t have time to wait. We are Absci Creating drugs at the speed of Ai